No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Express News | Spero Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)
Spero Therapeutics: Board Grants 116,667 Restricted Stk Unit Awards to New Employee >SPRO
Press Release: Spero Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Spero Therapeutics to Participate in H.C. Wainwright Annual BioConnect Investor Conference
Express News | HC Wainwright & Co. Reiterates Buy on Spero Therapeutics, Maintains $7 Price Target
Spero Therapeutics Analyst Ratings